Correlation Between Centessa Pharmaceuticals and PepGen
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and PepGen, you can compare the effects of market volatilities on Centessa Pharmaceuticals and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and PepGen.
Diversification Opportunities for Centessa Pharmaceuticals and PepGen
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Centessa and PepGen is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and PepGen go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and PepGen
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.26 times more return on investment than PepGen. However, Centessa Pharmaceuticals PLC is 3.91 times less risky than PepGen. It trades about -0.03 of its potential returns per unit of risk. PepGen is currently generating about -0.04 per unit of risk. If you would invest 1,635 in Centessa Pharmaceuticals PLC on December 29, 2024 and sell it today you would lose (184.00) from holding Centessa Pharmaceuticals PLC or give up 11.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. PepGen
Performance |
Timeline |
Centessa Pharmaceuticals |
PepGen |
Centessa Pharmaceuticals and PepGen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Centessa Pharmaceuticals and PepGen
The main advantage of trading using opposite Centessa Pharmaceuticals and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.The idea behind Centessa Pharmaceuticals PLC and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
PepGen vs. Pmv Pharmaceuticals | PepGen vs. MediciNova | PepGen vs. Pharvaris BV | PepGen vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |